Bosulif and Alprazolam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bosulif (bosutinib) and Alprazolam (alprazolam). Common drug interactions include arthralgia among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Bosulif and Alprazolam. It is created by eHealthMe based on reports of 64 people who take the same drugs from the FDA, and is updated regularly.

What is Bosulif?

Bosulif has active ingredients of bosutinib. eHealthMe is studying from 9,401 Bosulif users. Check the latest studies of Bosulif.

What is Alprazolam?

Alprazolam has active ingredients of alprazolam. It is often used in stress and anxiety. eHealthMe is studying from 134,864 Alprazolam users. Check the latest studies of Alprazolam.



On Jul, 14, 2026

64 people who take Bosulif and Alprazolam together, and have interactions are studied.

Bosulif and Alprazolam drug interactions.

What are the common drug interactions of Bosulif and Alprazolam, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  3. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  4. Drug hypersensitivity
  5. Electrocardiogram qt prolonged
  6. Fluid overload (too much fluid in the blood)
  7. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  8. Iron deficiency
  9. Onycholysis (detachment of the nail from the nail bed)
  10. Pulmonary oedema (fluid accumulation in the lungs)

male:

  1. Diarrhoea
  2. Depressed mood
  3. Lip swelling
  4. Nasopharyngitis (inflammation of the nasopharynx)
  5. Peripheral swelling
  6. Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
  7. Abnormal faeces (abnormal stool)
  8. Affect lability (emotional incontinence)
  9. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  10. Arthropathy

What are the common drug interactions of Bosulif and Alprazolam, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Pneumonia
  2. Abdominal pain
  3. Anaemia (lack of blood)
  4. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  5. Constipation
  6. Diarrhoea
  7. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  8. Electrocardiogram qt prolonged
  9. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  10. Iron deficiency

30-39:

  1. Abdominal pain
  2. Arthralgia (joint pain)
  3. Dyspnoea (difficult or laboured respiration)
  4. Hypersensitivity
  5. Nausea (feeling of having an urge to vomit)
  6. Platelet count increased
  7. Rash
  8. Urticaria (rash of round, red welts on the skin that itch intensely)
  9. Vomiting

40-49:

  1. Diarrhoea
  2. Nausea (feeling of having an urge to vomit)
  3. Abdominal pain upper
  4. Drug ineffective
  5. Dyspepsia (indigestion)
  6. Fatigue (feeling of tiredness)
  7. Platelet count decreased
  8. Pyrexia (fever)
  9. Retching (strong involuntary effort to vomit)
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

50-59:

  1. Abdominal discomfort
  2. Bone pain
  3. Depression
  4. Fatigue (feeling of tiredness)
  5. Infectious mononucleosis (infection usually caused by the epstein-barr virus)
  6. Oropharyngeal pain
  7. Pain of skin
  8. Skin disorder (skin disease)
  9. Hospitalisation
  10. Abdominal pain

60+:

  1. Diarrhoea
  2. Fatigue (feeling of tiredness)
  3. Arthralgia (joint pain)
  4. Cough
  5. Disturbance in attention
  6. Haematochezia (passage of stools containing blood)
  7. Impaired driving ability
  8. Insomnia (sleeplessness)
  9. Joint swelling
  10. Limb injury

What are the existing conditions these people have? *

  1. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 52 people, 81.25%
  2. High Blood Pressure: 10 people, 15.62%
  3. Pain: 9 people, 14.06%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 14.06%
  5. Sleep Disorder: 8 people, 12.50%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 8 people, 12.50%
  7. Pain In Extremity: 6 people, 9.38%
  8. Osteitis (a general term for inflammation of bone): 6 people, 9.38%
  9. Diabetes: 6 people, 9.38%
  10. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 9.38%

* Approximation only. Some reports may have incomplete information.

Do you take Bosulif and Alprazolam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Bosulif and Alprazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bosulif:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Alprazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bosulif and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Alprazolam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on bosutinib and alprazolam (the active ingredients of Bosulif and Alprazolam, respectively), and Bosulif and Alprazolam (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: